Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website ！
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
Reprinted: Clinical and Imaging Scoring of Peritoneal Carcinomatosis
Peritoneal cancer is primarily classified into two types: primary and secondary. Secondary peritoneal cancer accounts for more than 90% of clinical cases and is most often caused by metastasis from tumors such as gastric cancer, colorectal cancer, and ovarian cancer. Primary peritoneal cancer is rare and predominantly consists of high-grade serous carcinoma; its clinical presentation is insidious, with early symptoms typically limited to abdominal distension, abdominal pain, or mild ascites.
2026-05-28
Objective To compare the pharmacokinetics and adverse effects of cisplatin administered via intravenous infusion
2025-09-03
Compare the differences in perfusion flow rate and intraperitoneal temperature between surgical catheter placement and medical peritoneal puncture catheter placement in hyperthermic intraperitoneal chemotherapy (HIPEC) through animal experiments.
2025-09-03
To observe the effects of different temperatures during cavity circulatory thermal perfusion chemotherapy (CCTP) on the vital signs and abdominal organs of experimental dogs, and to determine the appropriate temperature for CCTP in experimental animals. Method: Dogs were used as experimental animals, and indicators were measured at abdominal cavity temperatures of 41, 42, and 43°C respectively.
2025-09-03
Thymoma is the most common type of tumor in the anterior mediastinum. The pleura is a hotspot for thymoma metastasis, known as the "host site"; pleural dissemination is a special mode of metastasis for thymoma. Pleural metastasis of thymoma may already exist at the initial diagnosis, representing stage M1a thymoma; or it may appear during follow-up after treatment, representing pleural recurrence (TPR). Surgery is an important treatment method for patients with pleural dissemination or TPR thymoma. Currently, there is no unified opinion on surgical approaches and methods. Simple surgery is difficult to achieve truly complete resection of pleural dissemination or TPR thymoma. Intraoperative hyperthermic intratumoral chemotherapy (HITOC) is an effective supplementary treatment, but internationally, the selection of HITOC regimens and setting of conditions are still under exploration; previous studies were mainly small sample, retrospective, and non-controlled studies with many confounding factors and limited clinical experience. This article summarizes and analyzes the diagnosis and treatment progress of pleural dissemination or TPR thymoma with surgery combined with HITOC, providing a theoretical basis for selecting reasonable treatment methods and formulating individualized treatment strategies.
2025-07-30
Expert Consensus on the Design of an Interventional Clinical Study of Malignant Pleural Effusion
2025-07-10
CACA China Integrated Diagnosis and Treatment Guidelines for Peritoneal Tumors - 2025 Edition
Peritoneal tumors are mainly classified as primary and secondary. Primary tumors originate from the peritoneum; common types include primary peritoneal cancer (Müllerian-type epithelial tumors, mainly serous carcinoma) and malignant peritoneal mesothelioma (MPM). Secondary tumors include various metastatic cancers, peritoneal sarcomatosis (PS), pseudomyxoma peritonei (PMP), and gliomatosis. Clinically, metastatic and epithelial malignant peritoneal tumors are more common, while primary and mesenchymal tumors are relatively rare and considered rare diseases.
2025-07-10
Colorectal cancer is one of the most common malignant tumors in China, ranking second and fourth in incidence and mortality rates among all malignant tumors, respectively. Metastasis and recurrence are the main causes of death in patients with colorectal cancer. The peritoneum is a common site of colorectal cancer metastasis, second only to liver and lung metastasis, but its prognosis is far worse than that of liver and lung metastasis.
2025-07-10
【New Law】Application and Key Points of Thoracic Thermal Perfusion Chemotherapy in Thoracic Treatment
Malignant pleural effusions (MPEs) are mainly seen in patients with advanced lung cancer (37.5%), breast cancer (16.8%), lymphoma (11.5%), genitourinary malignancies (9.4%), and gastrointestinal malignancies (6.9%); the median overall survival time for patients with MPEs and pleural metastases is 3-4 months.
2025-07-10
· China Good Doctor ·
· Good friends of human beings ·
Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China
Copyright Xi'an Good Doctor Medical Technology Co., Ltd.
Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143